… Taking another major step into the new biological era of Parkinson’s disease (PD), an international team of patient, research and industry leaders has proposed the first … in a living body — a significant paradigm shift after nearly two centuries of relying on outward, primarily …

… transdermal nicotine (nicotine patches) in patients at very early stages of Parkinson’s disease who do not yet require … the patient, symptomatic therapy is allowed. Relevance to Diagnosis/Treatment of Parkinson’s Disease :  The … the United States. Progress Report Results are expected in early 2017. October 2016   Learn More NIC-PD Launches …

… The Michael J. Fox Foundation and the Banner Sun Health Research Institute are partnering in a breakthrough program … group Thursday that the study would help translate science into useful tools. Marek, who also works closely with the … patients interested in enrolling should be in the early, or de novo, stages of the disease and not have …

… in autosomal recessive juvenile parkinsonism (ARJP) and early-onset Parkinson's disease (PD) caused by changes … parkin compared with models with normal parkin. Impact on Diagnosis/Treatment of Parkinson's disease: The results of … clarify whether KAR is a potential therapeutic target in early-onset Parkinson's or ARJP. Next Steps for Development: …

… quality of life for people living with PD. Our 2017 Research Year in Review details the critical programs, novel … could slow or stop disease progression. Two moved forward into Phase II testing . The first personalized medicine … safeguard federal research funding and access to care. Nearly 13,000 advocates -- representing all 435 congressional …

… information in MJFF's congressional directory . Federal Research Funding Congress is working to set next year's … of Health and Human Services, is the nation's medical research agency and the largest worldwide funder of PD … already been approved. The Senate version has been rolled into a larger package of bills that is still awaiting …